Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
ANI Pharmaceuticals Inc | Meredith W. Cook | SR. VP, GENERAL COUNSEL & SEC. | Sale of securities on an exchange or to another person at price $ 64.88 per share. | 14 Jul 2025 | 400 | 78,945 (0%) | 0% | 64.9 | 25,952 | Common Stock |
Houlihan Lokey Inc - Ordin... | Gillian B. Zucker | Director | Sale of securities on an exchange or to another person at price $ 191.65 per share. | 14 Jul 2025 | 200 | 5,533 (0%) | 0% | 191.7 | 38,330 | CLASS A COMMON STOCK |
Enovix Corporation | Kristina Truong | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.07 per share. | 13 Jul 2025 | 1,013 | 207,112 | - | 14.1 | 14,253 | Common Stock |
PSQ Holdings Inc - Ordinar... | James Rinn | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 250,000 | 250,000 | - | - | Restricted Stock Unit | |
UiPath Inc - Ordinary Shar... | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.71 per share. | 11 Jul 2025 | 45,000 | 5,193,376 | - | 12.7 | 572,094 | Class A Common Stock |
Kroger | Clyde R. Moore | Director | Sale of securities on an exchange or to another person at price $ 70.50 per share. | 11 Jul 2025 | 26,814 | 99,143 (0%) | 0% | 70.5 | 1,890,387 | Common Stock |
Genworth Financial Inc - O... | Samir B. Shah | Pres. & CEO, CareScout Svcs. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2025 | 15,964 | 15,965 | - | - | Restricted Stock Units | |
Genworth Financial Inc - O... | Samir B. Shah | Pres. & CEO, CareScout Svcs. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2025 | 15,964 | 54,618 (0%) | 0% | - | Common Stock | |
Klaviyo Inc - Ordinary Sha... | Amanda Whalen | Chief Financial Officer | 11 Jul 2025 | 15,000 | 449,193 | - | - | Series B Common Stock | ||
Klaviyo Inc - Ordinary Sha... | Amanda Whalen | Chief Financial Officer | 11 Jul 2025 | 15,000 | 532,831 | - | - | Series A Common Stock | ||
Klaviyo Inc - Ordinary Sha... | Amanda Whalen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 31.66 per share. | 11 Jul 2025 | 14,800 | 518,031 | - | 31.7 | 468,568 | Series A Common Stock |
Kroger | Clyde R. Moore | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Jul 2025 | 12,250 | 86,893 (0%) | 0% | 0 | Common Stock | |
Steelcase, Inc. - Ordinary... | Robert G. Krestakos | VP, Chief Operations Officer | Sale of securities on an exchange or to another person at price $ 10.63 per share. | 11 Jul 2025 | 12,000 | 127,912 (0%) | 0% | 10.6 | 127,546 | Class A Common Stock |
Universal Corp. | Johan C. Kroner | Senior VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 11,025 | 69,297 (0%) | 0% | 0 | Common Stock | |
Princeton Bancorp Inc | Stephen Distler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2025 | 10,000 | 0 | - | - | Option to purchase | |
Princeton Bancorp Inc | Stephen Distler | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.17 per share. | 11 Jul 2025 | 10,000 | 100,296 (1%) | 0% | 18.2 | 181,700 | Common Stock |
Princeton Bancorp Inc | Stephanie Adkins | Chief Lending Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.17 per share. | 11 Jul 2025 | 10,000 | 17,361 (0%) | 0% | 18.2 | 181,700 | Common Stock |
Princeton Bancorp Inc | Stephanie Adkins | Chief Lending Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2025 | 10,000 | 0 | - | - | Option to purchase | |
Genworth Financial Inc - O... | Samir B. Shah | Pres. & CEO, CareScout Svcs. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.32 per share. | 11 Jul 2025 | 8,160 | 46,458 (0%) | 0% | 7.3 | 59,731 | Common Stock |
Tejon Ranch Co. | Brett A. Brown | Executive Vice President / CFO | Sale of securities on an exchange or to another person at price $ 18.55 per share. | 11 Jul 2025 | 5,356 | 0 (0%) | 0% | 18.6 | 99,354 | Tejon Ranch Co. Common Stock |
Anixa Biosciences Inc | Amit Kumar | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.15 per share. | 11 Jul 2025 | 5,000 | 574,925 (2%) | 0% | 3.2 | 15,750 | Common Stock |
Doximity Inc - Ordinary Sh... | Regina M. Benjamin | Director | 11 Jul 2025 | 5,000 | 0 | - | - | Class B Common Stock | ||
Doximity Inc - Ordinary Sh... | Regina M. Benjamin | Director | 11 Jul 2025 | 5,000 | 21,618 | - | - | Class A Common Stock | ||
Doximity Inc - Ordinary Sh... | Regina M. Benjamin | Director | Sale of securities on an exchange or to another person at price $ 60.04 per share. | 11 Jul 2025 | 5,000 | 16,618 | - | 60.0 | 300,200 | Class A Common Stock |
Doximity Inc - Ordinary Sh... | Regina M. Benjamin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2025 | 5,000 | 366,138 | - | - | Stock Option (Right to Buy) | |
Doximity Inc - Ordinary Sh... | Regina M. Benjamin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2025 | 5,000 | 5,000 | - | - | Class B Common Stock | |
AGCO Corp. | Damon J. Audia | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 110.86 per share. | 11 Jul 2025 | 4,098 | 38,998 (0%) | 0% | 110.9 | 454,304 | Common Stock |
Leggett & Platt, Inc. | Joseph W. Mcclanathan | Director | Grant, award, or other acquisition of securities at price $ 8.10 per share. | 11 Jul 2025 | 3,794 | 100,545 (0%) | 0% | 8.1 | 30,750 | Common Stock |
Greenbrier Cos., Inc. | Wanda F. Felton | Director | Sale of securities on an exchange or to another person at price $ 54.31 per share. | 11 Jul 2025 | 3,652 | 3,000 (0%) | 0% | 54.3 | 198,341 | Common Stock |
German American Bancorp Inc | Zachary W. Bawel | Director | 11 Jul 2025 | 2,748 | 2,748 (0%) | 0% | 0 | Common Stock | ||
Aehr Test Systems | Gayn Erickson | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.11 per share. | 11 Jul 2025 | 2,489 | 278,081 (1%) | 0% | 14.1 | 35,120 | Common Stock |
EyePoint Pharmaceuticals Inc | Karen Zaderej | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2025 | 2,000 | 38,500 (0%) | 0% | 0 | Common Stock | |
EyePoint Pharmaceuticals Inc | Karen Zaderej | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2025 | 2,000 | 0 | - | - | Restricted Stock Units | |
Bellring Brands Inc | Darcy Horn Davenport | PRES. AND CEO | Sale of securities on an exchange or to another person at price $ 57.66 per share. | 11 Jul 2025 | 1,600 | 198,778 (0%) | 0% | 57.7 | 92,256 | Common Stock |
Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 193.47 per share. | 11 Jul 2025 | 1,450 | 435,455 (0%) | 0% | 193.5 | 280,533 | Class A Common Stock |
Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 193.47 per share. | 11 Jul 2025 | 1,450 | 434,371 (0%) | 0% | 193.5 | 280,533 | Class A Common Stock |
Accenture | Julie Spellman Sweet | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 281.42 per share. | 11 Jul 2025 | 1,276 | 9,084 (0%) | 0% | 281.4 | 359,089 | Class A ordinary shares |
AGCO Corp. | Eric P. Hansotia | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 110.86 per share. | 11 Jul 2025 | 1,107 | 281,103 (0%) | 0% | 110.9 | 122,722 | Common Stock |
Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 186.88 per share. | 11 Jul 2025 | 1,096 | 429,690 (0%) | 0% | 186.9 | 204,819 | Class A Common Stock |
Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 186.88 per share. | 11 Jul 2025 | 1,095 | 430,606 (0%) | 0% | 186.9 | 204,633 | Class A Common Stock |
Zurn Elkay Water Solutions... | David J. Pauli | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.79 per share. | 11 Jul 2025 | 1,090 | 60,359 (0%) | 0% | 37.8 | 41,191 | Common Stock |
Aehr Test Systems | Gayn Erickson | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.11 per share. | 11 Jul 2025 | 1,052 | 277,029 (1%) | 0% | 14.1 | 14,844 | Common Stock |
Aehr Test Systems | Chris P. Siu | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.11 per share. | 11 Jul 2025 | 1,045 | 76,578 (0%) | 0% | 14.1 | 14,745 | Common Stock |
Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 192.21 per share. | 11 Jul 2025 | 800 | 432,653 (0%) | 0% | 192.2 | 153,768 | Class A Common Stock |
Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 192.21 per share. | 11 Jul 2025 | 800 | 433,361 (0%) | 0% | 192.2 | 153,768 | Class A Common Stock |
GSK Plc - ADR | Charles A. Bancroft | Non-Executive Director,Senior Independent Director | Sale or transfer of securities back to the company at price $ 19.27 per share. | 11 Jul 2025 | 728 | 89,227 (0%) | 0% | 19.3 | 14,028 | Ords 0.31p |
Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 188.08 per share. | 11 Jul 2025 | 650 | 430,786 (0%) | 0% | 188.1 | 122,252 | Class A Common Stock |
Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 198.37 per share. | 11 Jul 2025 | 650 | 433,870 (0%) | 0% | 198.4 | 128,942 | Class A Common Stock |
Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 198.37 per share. | 11 Jul 2025 | 650 | 436,255 (0%) | 0% | 198.4 | 128,942 | Class A Common Stock |
Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 188.08 per share. | 11 Jul 2025 | 650 | 429,956 (0%) | 0% | 188.1 | 122,252 | Class A Common Stock |
Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 194.14 per share. | 11 Jul 2025 | 635 | 432,301 (0%) | 0% | 194.1 | 123,278 | Class A Common Stock |
Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 194.14 per share. | 11 Jul 2025 | 634 | 431,436 (0%) | 0% | 194.1 | 123,084 | Class A Common Stock |
Aehr Test Systems | Adil Engineer | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.11 per share. | 11 Jul 2025 | 580 | 47,167 (0%) | 0% | 14.1 | 8,184 | Common Stock |
Kroger | Megan N. Shaffer | Group Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.58 per share. | 11 Jul 2025 | 474 | 28,385 (0%) | 0% | 70.6 | 33,455 | Common Stock |
Aehr Test Systems | Vernon Rogers | Exec VP of Sales & Mktg. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.11 per share. | 11 Jul 2025 | 450 | 69,940 (0%) | 0% | 14.1 | 6,350 | Common Stock |
Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 197.33 per share. | 11 Jul 2025 | 450 | 429,240 (0%) | 0% | 197.3 | 88,799 | Class A Common Stock |
Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 197.33 per share. | 11 Jul 2025 | 450 | 431,701 (0%) | 0% | 197.3 | 88,799 | Class A Common Stock |
Accenture | Julie Spellman Sweet | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 282.12 per share. | 11 Jul 2025 | 443 | 8,641 (0%) | 0% | 282.1 | 124,977 | Class A ordinary shares |
Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 190.20 per share. | 11 Jul 2025 | 434 | 435,821 (0%) | 0% | 190.2 | 82,545 | Class A Common Stock |
Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 190.19 per share. | 11 Jul 2025 | 433 | 432,220 (0%) | 0% | 190.2 | 82,354 | Class A Common Stock |
Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 191.45 per share. | 11 Jul 2025 | 417 | 433,453 (0%) | 0% | 191.4 | 79,834 | Class A Common Stock |
Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 191.45 per share. | 11 Jul 2025 | 416 | 429,540 (0%) | 0% | 191.4 | 79,643 | Class A Common Stock |
Aehr Test Systems | Donald P. Richmond | CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.11 per share. | 11 Jul 2025 | 410 | 215,730 (0%) | 0% | 14.1 | 5,785 | Common Stock |
Accenture | Mauro Macchi | Chief Executive Officer-EMEA | Sale of securities on an exchange or to another person at price $ 281.43 per share. | 11 Jul 2025 | 372 | 2,411 (0%) | 0% | 281.4 | 104,692 | Class A ordinary shares |
Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 195.47 per share. | 11 Jul 2025 | 325 | 434,820 (0%) | 0% | 195.5 | 63,527 | Class A Common Stock |
Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 195.47 per share. | 11 Jul 2025 | 325 | 433,036 (0%) | 0% | 195.5 | 63,527 | Class A Common Stock |
Aehr Test Systems | Alistair N. Sporck | VP Contactor Business Unit | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.11 per share. | 11 Jul 2025 | 312 | 33,808 (0%) | 0% | 14.1 | 4,402 | Common Stock |
Aehr Test Systems | Vernon Rogers | Exec VP of Sales & Mktg. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.11 per share. | 11 Jul 2025 | 304 | 69,636 (0%) | 0% | 14.1 | 4,289 | Common Stock |
Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 196.43 per share. | 11 Jul 2025 | 300 | 434,520 (0%) | 0% | 196.4 | 58,930 | Class A Common Stock |
Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 196.43 per share. | 11 Jul 2025 | 300 | 429,240 (0%) | 0% | 196.4 | 58,930 | Class A Common Stock |
Leggett & Platt, Inc. | J. Tyson Hagale | EVP, Pres. - Bedding Products | Grant, award, or other acquisition of securities at price $ 8.13 per share. | 11 Jul 2025 | 284 | 139,700 (0%) | 0% | 8.1 | 2,308 | Common Stock |
Leggett & Platt, Inc. | Benjamin M. Burns | Executive Vice President - CFO | Grant, award, or other acquisition of securities at price $ 8.13 per share. | 11 Jul 2025 | 284 | 139,836 (0%) | 0% | 8.1 | 2,308 | Common Stock |
Leggett & Platt, Inc. | Karl G. Glassman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 8.62 per share. | 11 Jul 2025 | 277 | 1,425,579 (1%) | 0% | 8.6 | 2,389 | Common Stock |
Leggett & Platt, Inc. | Lindsey Nicole Odaffer | EVP - Chief HR Officer | Grant, award, or other acquisition of securities at price $ 8.12 per share. | 11 Jul 2025 | 237 | 55,930 (0%) | 0% | 8.1 | 1,925 | Common Stock |
Accenture | Julie Spellman Sweet | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 284.97 per share. | 11 Jul 2025 | 227 | 8,266 (0%) | 0% | 285.0 | 64,688 | Class A ordinary shares |
Aehr Test Systems | Donald P. Richmond | CTO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.11 per share. | 11 Jul 2025 | 225 | 215,505 (0%) | 0% | 14.1 | 3,175 | Common Stock |
Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 188.77 per share. | 11 Jul 2025 | 210 | 435,245 (0%) | 0% | 188.8 | 39,641 | Class A Common Stock |
Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 188.77 per share. | 11 Jul 2025 | 210 | 434,161 (0%) | 0% | 188.8 | 39,641 | Class A Common Stock |
GSK Plc - ADR | Vishal Sikka | Non-Executive Director | Sale or transfer of securities back to the company at price $ 19.27 per share. | 11 Jul 2025 | 206 | 20,568 (0%) | 0% | 19.3 | 3,970 | Ords 0.31p |
Steel Dynamics | Gabriel L. Shaheen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 201 | 82,013 (0%) | 0% | 0 | Common Stock | |
Klaviyo Inc - Ordinary Sha... | Amanda Whalen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 31.32 per share. | 11 Jul 2025 | 200 | 517,831 | - | 31.3 | 6,264 | Series A Common Stock |
Leggett & Platt, Inc. | Ryan Michael Kleiboeker | EVP-Chief Strategic Plan. Off. | Grant, award, or other acquisition of securities at price $ 8.14 per share. | 11 Jul 2025 | 196 | 82,999 (0%) | 0% | 8.1 | 1,596 | Common Stock |
Steel Dynamics | Bradley S. Seaman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 166 | 50,360 (0%) | 0% | 0 | Common Stock | |
Accenture | Julie Spellman Sweet | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 287.06 per share. | 11 Jul 2025 | 157 | 8,109 (0%) | 0% | 287.1 | 45,068 | Class A ordinary shares |
Steel Dynamics | Traci M. Dolan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 154 | 59,768 (0%) | 0% | 0 | Common Stock | |
Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 200.13 per share. | 11 Jul 2025 | 150 | 432,070 (0%) | 0% | 200.1 | 30,019 | Class A Common Stock |
Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 200.13 per share. | 11 Jul 2025 | 150 | 432,151 (0%) | 0% | 200.1 | 30,019 | Class A Common Stock |
Accenture | Julie Spellman Sweet | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 283.57 per share. | 11 Jul 2025 | 148 | 8,493 (0%) | 0% | 283.6 | 41,968 | Class A ordinary shares |
Accenture | Angela Beatty | Chief Leadership & HR Officer | Sale of securities on an exchange or to another person at price $ 281.34 per share. | 11 Jul 2025 | 145 | 5,307 (0%) | 0% | 281.3 | 40,795 | Class A ordinary shares |
Leggett & Platt, Inc. | J. Tyson Hagale | EVP, Pres. - Bedding Products | Grant, award, or other acquisition of securities at price $ 8.66 per share. | 11 Jul 2025 | 126 | 139,415 (0%) | 0% | 8.7 | 1,091 | Common Stock |
Leggett & Platt, Inc. | Benjamin M. Burns | Executive Vice President - CFO | Grant, award, or other acquisition of securities at price $ 8.66 per share. | 11 Jul 2025 | 126 | 139,552 (0%) | 0% | 8.7 | 1,091 | Common Stock |
Leggett & Platt, Inc. | Jennifer Joy Davis | EVP - GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 8.12 per share. | 11 Jul 2025 | 116 | 81,933 (0%) | 0% | 8.1 | 942 | Common Stock |
Edwards Lifesciences | Annette Bruls | CVP, EMEACLA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.80 per share. | 11 Jul 2025 | 109 | 14,171 (0%) | 0% | 78.8 | 8,589 | Common Stock |
Leggett & Platt, Inc. | Jennifer Joy Davis | EVP - GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 8.62 per share. | 11 Jul 2025 | 102 | 81,816 (0%) | 0% | 8.6 | 879 | Common Stock |
Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 201.05 per share. | 11 Jul 2025 | 100 | 435,145 (0%) | 0% | 201.1 | 20,105 | Class A Common Stock |
Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 201.05 per share. | 11 Jul 2025 | 100 | 432,936 (0%) | 0% | 201.1 | 20,105 | Class A Common Stock |
Kroger | Brian W. Nichols | Vice President & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.58 per share. | 11 Jul 2025 | 97 | 10,376 (0%) | 0% | 70.6 | 6,846 | Common Stock |
Leggett & Platt, Inc. | Ryan Michael Kleiboeker | EVP-Chief Strategic Plan. Off. | Grant, award, or other acquisition of securities at price $ 8.65 per share. | 11 Jul 2025 | 85 | 82,802 (0%) | 0% | 8.6 | 735 | Common Stock |
Leggett & Platt, Inc. | Tammy M. Trent | SVP - Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 8.14 per share. | 11 Jul 2025 | 83 | 66,726 (0%) | 0% | 8.1 | 676 | Common Stock |
Leggett & Platt, Inc. | Lindsey Nicole Odaffer | EVP - Chief HR Officer | Grant, award, or other acquisition of securities at price $ 8.68 per share. | 11 Jul 2025 | 78 | 55,692 (0%) | 0% | 8.7 | 677 | Common Stock |
Leggett & Platt, Inc. | Tammy M. Trent | SVP - Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 8.63 per share. | 11 Jul 2025 | 71 | 66,642 (0%) | 0% | 8.6 | 613 | Common Stock |
GSK Plc - ADR | Anne Beal | Non-Executive Director | Sale or transfer of securities back to the company at price $ 19.27 per share. | 11 Jul 2025 | 70 | 9,894 (0%) | 0% | 19.3 | 1,349 | Ords 0.31p |
Steel Dynamics | Sheree L. Bargabos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 69 | 25,276 (0%) | 0% | 0 | Common Stock | |
GSK Plc - ADR | Harry C Dietz | Non-Executive Director | Sale or transfer of securities back to the company at price $ 19.26 per share. | 11 Jul 2025 | 68 | 9,320 (0%) | 0% | 19.3 | 1,310 | Ords 0.31p |
GSK Plc - ADR | Hal V Barron | Non-Executive Director | Sale or transfer of securities back to the company at price $ 19.27 per share. | 11 Jul 2025 | 60 | 749,420 (0%) | 0% | 19.3 | 1,156 | Ords 0.31p |
Accenture | Mauro Macchi | Chief Executive Officer-EMEA | Sale of securities on an exchange or to another person at price $ 286.70 per share. | 11 Jul 2025 | 46 | 2,283 (0%) | 0% | 286.7 | 13,188 | Class A ordinary shares |
Accenture | Mauro Macchi | Chief Executive Officer-EMEA | Sale of securities on an exchange or to another person at price $ 284.53 per share. | 11 Jul 2025 | 43 | 2,329 (0%) | 0% | 284.5 | 12,235 | Class A ordinary shares |
Accenture | Mauro Macchi | Chief Executive Officer-EMEA | Sale of securities on an exchange or to another person at price $ 283.46 per share. | 11 Jul 2025 | 39 | 2,372 (0%) | 0% | 283.5 | 11,055 | Class A ordinary shares |
Arrow Financial Corp. | Philip C. Morris | Director | Other type of transaction at price $ 27.32 per share. | 11 Jul 2025 | 37 | 5,749 (0%) | 0% | 27.3 | 1,011 | Common Stock |
Accenture | Angela Beatty | Chief Leadership & HR Officer | Sale of securities on an exchange or to another person at price $ 285.00 per share. | 11 Jul 2025 | 29 | 5,259 (0%) | 0% | 285 | 8,265 | Class A ordinary shares |
GSK Plc - ADR | Jeannie Lee | Non-Executive Director | Sale or transfer of securities back to the company at price $ 19.27 per share. | 11 Jul 2025 | 22 | 2,648 (0%) | 0% | 19.3 | 424 | Ords 0.31p |
Accenture | Angela Beatty | Chief Leadership & HR Officer | Sale of securities on an exchange or to another person at price $ 283.79 per share. | 11 Jul 2025 | 19 | 5,288 (0%) | 0% | 283.8 | 5,392 | Class A ordinary shares |
Steel Dynamics | Luis M. Sierra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 18 | 10,763 (0%) | 0% | 0 | Common Stock | |
Steel Dynamics | Jennifer L. Hamann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 15 | 4,081 (0%) | 0% | 0 | Common Stock | |
Steel Dynamics | Richard P. Teets | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 13 | 5,052,332 (2%) | 0% | 0 | Common Stock | |
Accenture | Angela Beatty | Chief Leadership & HR Officer | Sale of securities on an exchange or to another person at price $ 286.40 per share. | 11 Jul 2025 | 10 | 5,249 (0%) | 0% | 286.4 | 2,864 | Class A ordinary shares |
Steel Dynamics | Kenneth W. Cornew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 6 | 36,283 (0%) | 0% | 0 | Common Stock | |
Worthington Industries, Inc. | Joseph B. Hayek | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 3 | 4,938 | - | - | Phantom Stock Acquired Under the Deferred Compensation Plan | |
Worthington Industries, Inc. | Kevin J. Chan | Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 3 | 129 | - | - | Phantom Stock | |
Stardust Power Inc. | Roshan Pujari | Director, CEO and Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 5,250,000 | 3,651,063 | - | 0 | Common Stock | |
Acushnet Holdings Corp | Yoon Soon Yoon | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 65.56 per share. | 10 Jul 2025 | 953,406 | 29,523,653 (39%) | 1% | 65.6 | 62,508,444 | Common Stock |
Acushnet Holdings Corp | Keun Chang Yoon | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 65.56 per share. | 10 Jul 2025 | 953,406 | 29,523,653 (39%) | 1% | 65.6 | 62,508,444 | Common Stock |
Acushnet Holdings Corp | Ho Yeon Lee | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 65.56 per share. | 10 Jul 2025 | 953,406 | 29,523,653 (39%) | 1% | 65.6 | 62,508,444 | Common Stock |
Udemy Inc | Ozzie J. Goldschmied | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 645,000 | 645,000 | - | 0 | Common Stock | |
Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 10 Jul 2025 | 300,000 | 6,000,000 (8%) | 0% | 40.2 | 12,047,640 | Common Stock | |
Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 10 Jul 2025 | 300,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 10 Jul 2025 | 300,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 10 Jul 2025 | 300,000 | 5,700,000 (8%) | 0% | 40.2 | 12,047,640 | Common Stock | |
Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 10 Jul 2025 | 300,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 10 Jul 2025 | 300,000 | 5,400,000 (7%) | 0% | 40.2 | 12,047,640 | Common Stock | |
Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 10 Jul 2025 | 300,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 10 Jul 2025 | 300,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 10 Jul 2025 | 300,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 10 Jul 2025 | 300,000 | 5,400,000 (7%) | 0% | 40.2 | 12,047,640 | Common Stock | |
Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 10 Jul 2025 | 300,000 | 5,700,000 (8%) | 0% | 40.2 | 12,047,640 | Common Stock | |
Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 10 Jul 2025 | 300,000 | 6,000,000 (8%) | 0% | 40.2 | 12,047,640 | Common Stock | |
Paychex | Martin Mucci | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2025 | 226,636 | 0 | - | - | Stock Option | |
Paychex | Martin Mucci | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 60.84 per share. | 10 Jul 2025 | 226,636 | 705,978 (0%) | 0% | 60.8 | 13,788,534 | Common Stock |
Paychex | Martin Mucci | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2025 | 208,590 | 0 | - | - | Stock Option | |
Paychex | Martin Mucci | Director, Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 60.84 per share. | 10 Jul 2025 | 208,590 | 628,507 (0%) | 0% | 60.8 | 12,690,616 | Common Stock |
Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 199,202 | 1,228,868 | - | 0 | Common Stock | |
Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 199,202 | 20,204 | - | 0 | Common Stock | |
Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 179,417 | 1,408,285 | - | 0 | Common Stock | |
Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 179,417 | 18,197 | - | 0 | Common Stock | |
Paychex | Martin Mucci | Director, Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 145.62 per share. | 10 Jul 2025 | 161,535 | 544,443 (0%) | 0% | 145.6 | 23,522,727 | Common Stock |
Global Net Lease Inc | Edward M. Weil | Director, CEO, President | Sale of securities on an exchange or to another person at price $ 7.61 per share. | 10 Jul 2025 | 150,000 | 584,053 (0%) | 0% | 7.6 | 1,141,500 | Common Stock |
Paychex | Martin Mucci | Director, Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 145.55 per share. | 10 Jul 2025 | 149,165 | 479,342 (0%) | 0% | 145.6 | 21,710,966 | Common Stock |
Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 148,312 | 14,450 | - | 0 | Common Stock | |
Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 148,312 | 955,338 | - | 0 | Common Stock | |
Paychex | Martin Mucci | Director, Chairman | Sale of securities on an exchange or to another person at price $ 145.17 per share. | 10 Jul 2025 | 97,526 | 446,917 (0%) | 0% | 145.2 | 14,157,849 | Common Stock |
Maravai LifeSciences Holdi... | Gregory T. Lucier | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 89,139 | 109,784 | - | 0 | Class A Common Stock | |
Maravai LifeSciences Holdi... | Gregory T. Lucier | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 89,139 | 55,123 | - | 0 | Class A Common Stock | |
Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 74,328 | 1,029,666 | - | 0 | Common Stock | |
Day One Biopharmaceuticals... | Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Jul 2025 | 74,328 | 147,702 | - | 0 | Common Stock | |
Grove Collaborative Holdin... | John B. Replogle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 59,200 | 59,200 | - | - | Restricted Stock Units | |
Grove Collaborative Holdin... | Kristine E. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 59,200 | 59,200 | - | - | Restricted Stock Units | |
Grove Collaborative Holdin... | David Glazer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 59,200 | 59,200 | - | - | Restricted Stock Units | |
Grove Collaborative Holdin... | Stuart Landesberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 59,200 | 59,200 | - | - | Restricted Stock Units | |
Grove Collaborative Holdin... | Naytri Shroff Sramek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 59,200 | 59,200 | - | - | Restricted Stock Units | |
UiPath Inc - Ordinary Shar... | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.06 per share. | 10 Jul 2025 | 45,000 | 5,238,376 | - | 13.1 | 587,651 | Class A Common Stock |
Planet Labs PBC - Ordinary... | Carl Bass | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 32,468 | 317,530 | - | 0 | Class A Common Stock | |
Planet Labs PBC - Ordinary... | Gary B. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 32,468 | 32,468 | - | 0 | Class A Common Stock | |
Planet Labs PBC - Ordinary... | Kristen O. Robinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 32,468 | 298,562 | - | 0 | Class A Common Stock | |
Planet Labs PBC - Ordinary... | Ita M. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 32,468 | 285,053 | - | 0 | Class A Common Stock | |
Planet Labs PBC - Ordinary... | Vijaya Gadde | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 32,468 | 270,169 | - | 0 | Class A Common Stock | |
Planet Labs PBC - Ordinary... | John W. Raymond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 32,468 | 43,608 | - | 0 | Class A Common Stock | |
Ispire Technology Inc | Brent Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 29,784 | 50,782 | - | 0 | Common Stock | |
Perrigo Company plc | Patrick Lockwood-Taylor | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2025 | 28,326 | 28,325 | - | - | Restricted Stock Units | |
Perrigo Company plc | Patrick Lockwood-Taylor | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.27 per share. | 10 Jul 2025 | 28,326 | 95,586 (0%) | 0% | 27.3 | 772,450 | Ordinary Shares |
Ispire Technology Inc | John Fargis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 27,178 | 46,599 | - | 0 | Common Stock | |
Ispire Technology Inc | Christopher Robert Burch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 27,178 | 41,658 | - | 0 | Common Stock | |
Roku Inc - Ordinary Shares... | Anthony Wood | Director, CEO and Chairman BOD, Ten Percent Owner | 10 Jul 2025 | 25,000 | 16,853,111 | - | - | Class B Common Stock | ||
Roku Inc - Ordinary Shares... | Anthony Wood | Director, CEO and Chairman BOD, Ten Percent Owner | 10 Jul 2025 | 25,000 | 25,000 (0%) | 0% | - | Class A Common Stock | ||
Snowflake Inc - Ordinary S... | Benoit Dageville | Director, President of Products | Sale of securities on an exchange or to another person at price $ 221.83 per share. | 10 Jul 2025 | 25,000 | 58,325 | - | 221.8 | 5,545,750 | Common Stock |
Snowflake Inc - Ordinary S... | Benoit Dageville | Director, President of Products | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.74 per share. | 10 Jul 2025 | 25,000 | 83,325 | - | 0.7 | 18,500 | Common Stock |
Snowflake Inc - Ordinary S... | Benoit Dageville | Director, President of Products | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2025 | 25,000 | 394,863 | - | - | Stock Option (Right to Buy) | |
Symbotic Inc - Ordinary Sh... | William M. Boyd | Chief Strategy Officer | Other type of transaction at price $ 0.00 per share. | 10 Jul 2025 | 25,000 | 25,000 | - | - | Symbotic Holdings Units | |
Symbotic Inc - Ordinary Sh... | William M. Boyd | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 49.00 per share. | 10 Jul 2025 | 25,000 | 34,544 | - | 49 | 1,225,000 | Class A Common Stock |
Symbotic Inc - Ordinary Sh... | William M. Boyd | Chief Strategy Officer | Other type of transaction at price $ 0.00 per share. | 10 Jul 2025 | 25,000 | 59,544 | - | - | Class A Common Stock | |
Symbotic Inc - Ordinary Sh... | William M. Boyd | Chief Strategy Officer | Other type of transaction at price $ 0.00 per share. | 10 Jul 2025 | 25,000 | 25,000 | - | - | Class V-1 Common Stock | |
Sunopta, Inc. | Danielle Marie Duzan | CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 24,834 | 24,834 | - | - | Restricted Stock Units | |
Arcutis Biotherapeutics Inc | Patrick E. Burnett | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2025 | 23,000 | 138,468 (0%) | 0% | 0 | Common Stock | |
Arcutis Biotherapeutics Inc | Patrick E. Burnett | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2025 | 23,000 | 178,250 | - | - | Stock Option (right to buy) | |
Arcutis Biotherapeutics Inc | Patrick E. Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 15.05 per share. | 10 Jul 2025 | 23,000 | 115,468 (0%) | 0% | 15.0 | 346,047 | Common Stock |
EyePoint Pharmaceuticals Inc | Jay S. Duker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2025 | 16,667 | 17,653 (0%) | 0% | 0 | Common Stock | |
EyePoint Pharmaceuticals Inc | Jay S. Duker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2025 | 16,667 | 16,667 | - | - | Restricted Stock Units | |
Akero Therapeutics Inc | Andrew Cheng | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 51.73 per share. | 10 Jul 2025 | 15,314 | 520,757 (1%) | 0% | 51.7 | 792,224 | Common Stock |
Photronics, Inc. | Mitchell G. Tyson | Director | Sale of securities on an exchange or to another person at price $ 19.97 per share. | 10 Jul 2025 | 15,000 | 56,927 (0%) | 0% | 20.0 | 299,550 | COMMON STOCK |
Akero Therapeutics Inc | Andrew Cheng | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 50.57 per share. | 10 Jul 2025 | 14,686 | 536,071 (1%) | 0% | 50.6 | 742,671 | Common Stock |
Perrigo Company plc | Patrick Lockwood-Taylor | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.27 per share. | 10 Jul 2025 | 14,234 | 81,352 (0%) | 0% | 27.3 | 388,161 | Ordinary Shares |
Roku Inc - Ordinary Shares... | Anthony Wood | Director, CEO and Chairman BOD, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 89.68 per share. | 10 Jul 2025 | 14,048 | 5,801 (0%) | 0% | 89.7 | 1,259,825 | Class A Common Stock |
Planet Labs PBC - Ordinary... | Ita M. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 13,915 | 298,968 | - | 0 | Class A Common Stock | |
Corning Incorporated | Jordana Daryl Kammerud | Senior Vice President & CHRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.26 per share. | 10 Jul 2025 | 12,391 | 49,574 (0%) | 0% | 52.3 | 647,554 | Common Stock |
AN2 Therapeutics Inc | Kabeer Aziz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 11,875 | 30,552 | - | 0 | Common Stock | |
AN2 Therapeutics Inc | Gilbert Lynn Marks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 11,875 | 53,382 | - | 0 | Common Stock | |
EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2025 | 11,111 | 216,547 (0%) | 0% | 0 | Common Stock | |
EyePoint Pharmaceuticals Inc | Nancy S. Lurker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2025 | 11,111 | 11,112 | - | - | Restricted Stock Units | |
H.B. Fuller Company | Robert J. Martsching | VP, Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.38 per share. | 10 Jul 2025 | 9,546 | 24,525 (0%) | 0% | 33.4 | 318,645 | Common Stock |
H.B. Fuller Company | Robert J. Martsching | VP, Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2025 | 9,546 | 0 | - | - | Employee Stock Option (Right-to-Buy) | |
H.B. Fuller Company | Robert J. Martsching | VP, Corporate Controller | Sale of securities on an exchange or to another person at price $ 64.30 per share. | 10 Jul 2025 | 9,546 | 14,979 (0%) | 0% | 64.3 | 613,852 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.